pre-seed
Stage
2
Investors
About
FluoretiQ develops fast, accurate point-of-care diagnostics to improve antibiotic stewardship and combat antimicrobial resistance. Their technology platforms enable rapid bacterial identification and antibiotic susceptibility testing, supporting evidence-based treatments and reducing misuse of antibiotics.
Explore FluoretiQ Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.